by june 1987 worldwide investigators from 37 centres in 12 countries had completed epidemiological susceptibility testing studies comparing the in-vitro activity of fleroxacin with that of ciprofloxacin , norfloxacin and other antibacterials .
C0085161
fleroxacin
C0008809
ciprofloxacin